ARCHIVES

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

In Brief: BMS Chemistry Awards to Honor Fu, Wood; Groshow Joins NCI; Bowman Moves to TJU

January 15, 1999

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

Waxman To Speak At AACI Meeting

January 12, 1979

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

NIH Negotiating On Straus Grant; Committee Asks for One Probe

July 17, 1981